Review
Published on 12 Nov 2024
From microbes to medicine: harnessing the power of the microbiome in esophageal cancer
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1450927
- 256 views
Type at least 3 characters
40,848 articles
Articles
Mini Review
Published on 12 Nov 2024
Applications of single-cell RNA sequencing in rheumatoid arthritis
in Autoimmune and Autoinflammatory Disorders: Autoinflammatory Disorders
Frontiers in Immunology
doi 10.3389/fimmu.2024.1491318
- 218 views
Original Research
Published on 12 Nov 2024
The established of a machine learning model for predicting the efficacy of adjuvant interferon alpha1b in patients with advanced melanoma
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1495329
- 249 views
Original Research
Published on 12 Nov 2024
Oral exposure to high concentrations of polystyrene microplastics alters the intestinal environment and metabolic outcomes in mice
in Inflammation
Frontiers in Immunology
doi 10.3389/fimmu.2024.1407936
- 420 views
Original Research
Published on 12 Nov 2024
Dual blockade of IL-17A and IL-36 pathways via a bispecific antibody exhibits enhanced anti-inflammatory potency
in Autoimmune and Autoinflammatory Disorders : Autoimmune Disorders
Frontiers in Immunology
doi 10.3389/fimmu.2024.1434127
- 349 views
Original Research
Published on 12 Nov 2024
Praziquantel and factor H recruitment differentially affect the susceptibility of Schistosoma mansoni to complement-mediated damage
in Parasite Immunology
Frontiers in Immunology
doi 10.3389/fimmu.2024.1474358
- 243 views
Original Research
Published on 12 Nov 2024
Insulin-degrading enzyme regulates insulin-directed cellular autoimmunity in murine type 1 diabetes
in Autoimmune and Autoinflammatory Disorders : Autoimmune Disorders
Frontiers in Immunology
doi 10.3389/fimmu.2024.1474453
- 282 views
Original Research
Published on 12 Nov 2024
Changes to inflammatory markers during 5 years of viral suppression and during viral blips in people with HIV initiating different integrase inhibitor based regimens
in Viral Immunology
Frontiers in Immunology
doi 10.3389/fimmu.2024.1488799
- 379 views
Original Research
Published on 12 Nov 2024
Integrated multiomics characterization reveals cuproptosis-related hub genes for predicting the prognosis and clinical efficacy of ovarian cancer
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1452294
- 344 views
Original Research
Accepted on 11 Nov 2024
Peripheral Immune Characteristics and Subset Disorder in Reproductive Females with Endometriosis
in Immunological Tolerance and Regulation
Frontiers in Immunology
doi 10.3389/fimmu.2024.1431175
- 120 views
Clinical Trial
Accepted on 11 Nov 2024
The Evaluation of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of SM17 in Healthy Volunteers, Results from Preclinical Models and a First-in-Human, Randomized, Double Blinded Clinical Trial
in Cytokines and Soluble Mediators in Immunity
Frontiers in Immunology
doi 10.3389/fimmu.2024.1495540
Systematic Review
Accepted on 11 Nov 2024
Abscopal effect of focused ultrasound combined immunotherapy in animal solid tumor model: a systematic reviews and meta-analysis
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1474343
Original Research
Accepted on 11 Nov 2024
Hypoimmunogenic CD19 CAR-NK cells derived from embryonic stem cells suppress the progression of human B-cell malignancies in xenograft animals
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1504459
Original Research
Accepted on 11 Nov 2024
A novel molecular classification system based on the molecular feature score identifies patients sensitive to immune therapy and target therapy
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1466069
- 151 views
Original Research
Accepted on 11 Nov 2024
SON-1010 -An Albumin-binding IL-12 Fusion Protein with Improved Cytokine Half-life Targets Tumors and Enhances Therapeutic Efficacy
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1493257
Original Research
Accepted on 11 Nov 2024
Serum transgelin is a novel prognostic biomarker for COVID-19 patients
in Viral Immunology
Frontiers in Immunology
doi 10.3389/fimmu.2024.1423182